Tumor-associated DCs, especially pDCs, showed upregulated ICOSL expression compared to normal tissue, facilitating stronger interactions with T cells and notably promoting CD8+ T-cell activation through the ICOS–ICOSL pathway. This evidence concerns the gene CD8A and neoplasm.